MedVellum
MedVellum
Back to Library
Paediatrics
Infectious Disease
General Practice
Dermatology

Chickenpox

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Bacterial superinfection (invasive GAS — necrotising fasciitis, sepsis)
  • Pneumonitis (adults, pregnant women, immunocompromised)
  • Encephalitis/cerebellar ataxia
  • Immunocompromised patient with chickenpox
  • Pregnant woman exposed to chickenpox (or with chickenpox)
  • Neonate exposed to maternal chickenpox around delivery
Overview

Chickenpox

1. Clinical Overview

Summary

Chickenpox (varicella) is a highly contagious primary infection caused by varicella-zoster virus (VZV), a herpesvirus. It is characterised by a generalised vesicular rash (crops of vesicles in different stages) and is typically a mild, self-limiting illness in immunocompetent children. Complications include secondary bacterial skin infection (Group A Streptococcus, Staphylococcus aureus), pneumonitis, encephalitis, and cerebellar ataxia. Chickenpox is more severe in adults, pregnant women, neonates, and immunocompromised individuals. After primary infection, VZV remains latent in dorsal root ganglia and can reactivate later in life as herpes zoster (shingles). Prevention is through vaccination (live attenuated vaccine) and post-exposure prophylaxis with varicella-zoster immunoglobulin (VZIG) in high-risk contacts.

Key Facts

  • Causative agent: Varicella-zoster virus (VZV) — Herpesviridae family
  • Transmission: Respiratory droplets and direct contact with vesicle fluid; highly contagious
  • Incubation period: 10-21 days (typically 14-16 days)
  • Infectious period: 2 days before rash until all lesions crusted over (usually 5-7 days)
  • Attack rate: >90% in susceptible household contacts
  • Classic rash: "Dew drops on a rose petal" — vesicles on erythematous base
  • Rash distribution: Centripetal (trunk → spreads to face, limbs); crops at different stages
  • Complication rate: 2-5% in children; higher in adults and immunocompromised
  • Latency: VZV dormant in dorsal root ganglia; reactivates as shingles
  • Vaccine: Live attenuated; part of routine childhood immunisation in many countries

Clinical Pearls

"Starry Sky Rash": The hallmark of chickenpox is crops of vesicles at different stages of development (macules, papules, vesicles, crusts) — the "starry sky" appearance. This distinguishes it from monomorphic rashes.

"No NSAIDs": Avoid NSAIDs (ibuprofen) in chickenpox — associated with increased risk of secondary necrotising fasciitis. Use paracetamol only for fever.

"Adults Get Sicker": Chickenpox is generally mild in children but can be severe in adults, with higher rates of pneumonitis and hospitalisation. Adults should receive aciclovir if presenting within 24 hours.

"Pregnancy Alert": Chickenpox in pregnancy carries risks for mother (varicella pneumonitis) and fetus (congenital varicella syndrome in early pregnancy; severe neonatal varicella if infected around delivery).

"The Prodrome Is Non-Specific": Fever and malaise for 1-2 days before the rash is common. Don't dismiss non-specific symptoms in contacts of known cases.

Why This Matters Clinically

While chickenpox is usually benign in healthy children, it can be life-threatening in high-risk groups (immunocompromised, neonates, pregnant women). Recognising complications early (bacterial superinfection, pneumonitis, encephalitis) and knowing when to use antivirals is essential. Post-exposure prophylaxis with VZIG can prevent or modify disease in high-risk contacts.[1,2]


2. Epidemiology

Incidence & Prevalence

ParameterData
Pre-vaccine era incidence~90% infected by adolescence in temperate climates
UK incidence~600,000 cases/year (mostly children)
Hospitalisation rate~500 per year in UK (children); higher in adults
Deaths~20 per year in UK (mainly adults, immunocompromised)
Peak age1-9 years
SeasonalityLate winter to early spring peak

Demographics

FactorDetails
Age distributionPeak incidence 1-9 years (90% <15 years in unvaccinated populations)
Adults without immunity~10% of adults susceptible; more severe disease
Tropical climatesHigher proportion of adult cases (lower childhood transmission)

Risk Factors for Severe Disease

FactorRiskNotes
Age >14 years15-25x mortality vs childrenIncreased pneumonitis risk
Pregnancy5x increased pneumonitisRisk of congenital varicella syndrome
NeonatesVery high mortality if maternal infection near termDisseminated disease
Immunocompromised10-30% mortality without treatmentLeukaemia, HIV, transplant, steroids
Chronic skin disease (eczema)More extensive diseaseEczema herpeticum overlap rare but possible

3. Pathophysiology

Mechanism

Step 1: Primary Infection

  • VZV enters via respiratory mucosa (droplet transmission)
  • Initial viral replication in nasopharynx and regional lymph nodes

Step 2: Primary Viraemia (~Day 4-6)

  • Virus enters bloodstream
  • Spreads to reticuloendothelial system (liver, spleen)
  • Further amplification

Step 3: Secondary Viraemia (~Day 10-14)

  • Massive viral release into bloodstream
  • Virus transported to skin and mucous membranes
  • Prodrome of fever and malaise begins

Step 4: Skin Manifestations

  • VZV infects epidermal cells
  • Vesicle formation: Intraepidermal, unilocular vesicles
  • "Dew drops on a rose petal" — clear vesicles on erythematous base
  • Progressive stages: Macule → papule → vesicle → pustule → crust
  • Crops appear over several days (different stages simultaneously)

Step 5: Latency

  • VZV travels via sensory nerves to dorsal root ganglia
  • Establishes lifelong latent infection
  • Reactivation later in life = Herpes Zoster (shingles)

Immune Response

ComponentRole
Innate immunityInitial response; limits early spread
Cell-mediated immunity (CMI)Critical for clearance; deficiency = severe disease
Humoral immunity (antibodies)Prevents reinfection; can be measured (IgG serology)
Passive antibody (VZIG)Provides temporary protection post-exposure

4. Clinical Presentation

Prodrome (1-2 Days Before Rash)

SymptomNotes
FeverLow-grade (37.5-39°C); higher in adults
MalaiseGeneral unwellness
HeadacheNon-specific
AnorexiaCommon in children

Rash Characteristics

FeatureDescription
Appearance"Dew drops on a rose petal" — clear vesicles on erythematous base
EvolutionMacule → Papule → Vesicle → Pustule → Crust (24-48 hours per lesion)
DistributionCentripetal: Trunk first → Face → Limbs
CropsNew lesions appear in waves over 3-5 days; lesions at different stages simultaneously
Mucosal involvementOral vesicles/ulcers, genital lesions
Number of lesionsTypically 250-500; range 10 to >1000
PruritusIntense itching characteristic
CrustingAll lesions crust by day 5-7 (marks end of infectious period)

Red Flags

[!CAUTION] Red Flags — Require Urgent Assessment:

  • High persistent fever after day 4 (secondary bacterial infection)
  • Rapidly spreading redness/warmth around lesions (cellulitis, necrotising fasciitis)
  • Respiratory symptoms (cough, dyspnoea, tachypnoea) — varicella pneumonitis
  • Neurological symptoms (ataxia, altered consciousness, seizures)
  • Immunocompromised patient with chickenpox
  • Pregnant woman with chickenpox (or post-exposure)
  • Neonate with chickenpox or exposed <7 days post-delivery

5. Clinical Examination

Skin Examination

Key Findings:

  • Vesicles on erythematous base ("dew drop on rose petal")
  • Lesions at different stages (macules, vesicles, crusts)
  • Centripetal distribution (trunk > extremities)
  • Mucosal ulcers (oral, conjunctival)
  • Check for secondary infection (honey crusting, surrounding erythema)

Documentation:

  • Approximate lesion count (mild <50, moderate 50-250, severe >250)
  • Signs of bacterial superinfection
  • Stage of lesions (all crusted = no longer infectious)

Systemic Examination (If Complications Suspected)

SystemAssessmentConcern
RespiratoryCough, tachypnoea, cracklesVaricella pneumonitis
NeurologicalAtaxia, altered GCS, neck stiffnessEncephalitis, cerebellar ataxia
SkinSpreading erythema, pain, crepitusNecrotising fasciitis (GAS/S. aureus)

6. Investigations

Routine (Uncomplicated Cases)

No investigations typically required. Diagnosis is clinical.

Investigations If Uncertainty or Severe Disease

InvestigationIndicationExpected Findings
VZV PCR (vesicle fluid)Atypical rash; confirmation neededPositive
Tzanck smearRapid bedside test (vesicle scraping)Multinucleated giant cells (non-specific)
VZV IgM/IgGConfirm immunity; epidemiologicalIgM positive = acute; IgG positive = past infection/immunity
CXRRespiratory symptomsDiffuse nodular infiltrates (pneumonitis)
FBC, CRPBacterial superinfection suspectedLeukocytosis, raised CRP
LFTsHepatitis (can occur)Transaminitis
LPNeurological symptomsLymphocytic pleocytosis (encephalitis)

7. Management

Management Algorithm

                 CHICKENPOX MANAGEMENT
                         ↓
┌───────────────────────────────────────────────────────────────┐
│               ASSESS RISK STATUS                              │
├───────────────────────────────────────────────────────────────┤
│  LOW RISK (Typical):                                          │
│  ➤ Healthy child (age 1-14 years)                            │
│  ➤ No chronic disease or immunosuppression                   │
│  ➤ No complications                                          │
├───────────────────────────────────────────────────────────────┤
│  HIGH RISK:                                                   │
│  ➤ Adults (&gt;14 years)                                        │
│  ➤ Immunocompromised (steroids, chemo, HIV)                  │
│  ➤ Pregnant women                                            │
│  ➤ Neonates                                                  │
│  ➤ Chronic lung/skin disease                                 │
│  ➤ Smokers                                                   │
└───────────────────────────────────────────────────────────────┘
                         ↓
┌───────────────────────────────────────────────────────────────┐
│         MANAGEMENT: LOW-RISK (HEALTHY CHILD)                  │
├───────────────────────────────────────────────────────────────┤
│  SUPPORTIVE CARE:                                             │
│  ➤ Paracetamol for fever (AVOID NSAIDs)                      │
│  ➤ Antihistamines (chlorphenamine) for itch                  │
│  ➤ Calamine lotion                                           │
│  ➤ Keep nails short; consider mittens (prevent scratching)   │
│  ➤ Tepid baths                                               │
│  ➤ Adequate fluids                                           │
│                                                               │
│  EXCLUSION:                                                   │
│  ➤ Exclude from school until all lesions crusted (~5-7 days) │
│                                                               │
│  NO ANTIVIRALS needed for typical healthy child               │
└───────────────────────────────────────────────────────────────┘
                         ↓
┌───────────────────────────────────────────────────────────────┐
│         MANAGEMENT: HIGH-RISK INDIVIDUALS                     │
├───────────────────────────────────────────────────────────────┤
│  ANTIVIRALS (within 24 hours of rash onset):                  │
│  ➤ Aciclovir 800 mg 5x daily (adults) for 7 days             │
│  ➤ Aciclovir 20 mg/kg QDS (children high-risk) for 5 days    │
│  ➤ IV aciclovir for immunocompromised/pneumonitis/enceph     │
│                                                               │
│  CONSIDER HOSPITAL ADMISSION:                                 │
│  ➤ Immunocompromised                                         │
│  ➤ Pneumonitis (cough, dyspnoea, hypoxia)                    │
│  ➤ Encephalitis (ataxia, altered consciousness)              │
│  ➤ Secondary bacterial infection (IV antibiotics if severe)  │
└───────────────────────────────────────────────────────────────┘
                         ↓
┌───────────────────────────────────────────────────────────────┐
│               SPECIAL SITUATIONS                              │
├───────────────────────────────────────────────────────────────┤
│  PREGNANCY (Varicella in pregnancy):                          │
│  ➤ Aciclovir if ≥20 weeks gestation                          │
│  ➤ Consider admission (risk of pneumonitis)                  │
│  ➤ If &lt;20 weeks: risk of congenital varicella syndrome       │
│  ➤ If near term: risk of severe neonatal varicella           │
│                                                               │
│  NEONATE:                                                     │
│  ➤ IV aciclovir immediately                                  │
│  ➤ High mortality if untreated                               │
│                                                               │
│  POST-EXPOSURE PROPHYLAXIS (within 10 days of exposure):      │
│  ➤ VZIG for high-risk contacts (pregnant, neonate, immuno)   │
│  ➤ Vaccine (if eligible) within 5 days of exposure           │
└───────────────────────────────────────────────────────────────┘

Post-Exposure Prophylaxis

AgentIndicationTiming
VZIGImmunocompromised; pregnant (non-immune); neonatesWithin 10 days of exposure
Varicella vaccineHealthy non-immune contactsWithin 3-5 days of exposure

Why Avoid NSAIDs?

  • Association with invasive Group A Streptococcal infection
  • Increased risk of necrotising fasciitis in chickenpox
  • NICE and PHE advise paracetamol only for fever

8. Complications

Early Complications

ComplicationIncidenceManagement
Secondary bacterial skin infection5-10%Antibiotics (flucloxacillin); watch for GAS
Necrotising fasciitisRare but severeUrgent surgical debridement + IV antibiotics
Varicella pneumonitis1:400 adultsIV aciclovir; respiratory support
Encephalitis1:4,000Supportive; consider IV aciclovir
Cerebellar ataxia1:4,000Self-limiting (usually); supportive
ThrombocytopeniaRareUsually self-limiting

Late Complications

ComplicationNotes
Herpes zoster (shingles)VZV reactivation; typically years later
Post-herpetic neuralgiaComplication of shingles (not primary chickenpox)
ScarringFrom scratching/secondary infection

Pregnancy-Specific Complications

Timing of Maternal InfectionRisk
Weeks 1-120.5% risk of congenital varicella syndrome (limb hypoplasia, cicatricial skin lesions, eye abnormalities, neurological damage)
Weeks 13-202% risk of congenital varicella syndrome
Weeks 20+Shingles in infancy; no congenital syndrome
5 days before to 2 days after deliverySevere neonatal varicella (up to 30% mortality without treatment)

9. Prognosis & Outcomes

Outcomes in Healthy Children

OutcomeExpected
Duration of illness5-10 days
Full recovery>99%
Mortality~1 per 100,000 cases
ScarringCommon if scratching/secondary infection

Outcomes in High-Risk Groups

GroupRisk
Adults25x higher mortality than children
Immunocompromised (untreated)10-30% mortality
Pregnant (pneumonitis)Up to 10% mortality without treatment
Neonatal varicella (untreated)20-30% mortality

10. Evidence & Guidelines

Key Guidelines

GuidelineOrganisationYearKey Points
Chickenpox CKSNICEUpdated 2023Diagnosis, management, referral criteria
Post-exposure prophylaxisPHE/UKHSA2019VZIG indications, timing
Varicella vaccinationJCVI/Green Book2022Vaccine schedules, targeted use

Landmark Studies

Varicella Vaccine Efficacy (Kuter et al. 1991)

  • Demonstrated 95% efficacy in preventing varicella
  • Foundation for routine childhood vaccination
  • PMID: 1651974

NSAIDs and Necrotising Fasciitis (Lesko et al. 2001)

  • Case-control study showing association between NSAIDs and NF in chickenpox
  • Basis for avoiding ibuprofen
  • PMID: 11178117

Evidence Strength

InterventionLevelEvidence
Varicella vaccination1aRCTs, real-world effectiveness data
Aciclovir in high-risk groups1bRCTs
Avoidance of NSAIDs2aObservational studies
VZIG for post-exposure prophylaxis2aCohort studies

11. Patient/Layperson Explanation

What is Chickenpox?

Chickenpox is a common and very contagious infection caused by the varicella-zoster virus. It causes an itchy rash of blisters that appear all over the body. Most children get it before age 10.

What are the symptoms?

  • Fever and feeling unwell for 1-2 days
  • Rash that starts as small red spots, then becomes blisters filled with fluid
  • Blisters appear in waves — you'll see spots at different stages at the same time
  • Very itchy
  • Blisters eventually dry up and form scabs

How is it spread?

Chickenpox is very contagious. It spreads through:

  • Coughs and sneezes (airborne droplets)
  • Direct contact with blister fluid

A child is infectious from 2 days before the rash appears until all blisters have crusted over (usually 5-7 days).

How to treat it at home

  • Give paracetamol (NOT ibuprofen) for fever and discomfort
  • Use calamine lotion or cooling gels to soothe itching
  • Give antihistamines (like Piriton) to help with itching
  • Keep fingernails short and consider mittens at night
  • Dress in loose, cool clothing
  • Oatmeal baths can be soothing
  • Keep your child hydrated

When to call a doctor

Seek medical advice if:

  • High fever lasting more than 4 days
  • Rash becomes very red, warm, or painful (infection)
  • Difficulty breathing or persistent cough
  • Unusual drowsiness, confusion, or headache
  • Your child won't drink or is dehydrated
  • Your child is very young (<1 year), immunocompromised, or unwell

12. References

Guidelines

  1. NICE Clinical Knowledge Summaries. Chickenpox. 2023. cks.nice.org.uk

  2. UKHSA. Guidance on varicella-zoster post-exposure prophylaxis. 2019. gov.uk

Key Studies

  1. Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1991;10(10):719-722. PMID: 1651974

  2. Lesko SM, O'Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics. 2001;107(5):1108-1115. PMID: 11331692

Reviews

  1. Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365-1376. PMID: 17046470

  2. NHS. Chickenpox information. nhs.uk/conditions/chickenpox


13. Examination Focus

High-Yield Exam Topics

TopicKey Points
Rash description"Dew drops on a rose petal"; crops at different stages; centripetal distribution
Infectious period2 days before rash until all lesions crusted (~5-7 days)
Avoid NSAIDsAssociation with necrotising fasciitis
Aciclovir indicationsAdults, immunocompromised, pregnant, within 24h of rash onset
VZIGFor high-risk contacts (immunocompromised, pregnant, neonate) within 10 days
LatencyVZV dormant in dorsal root ganglia → reactivates as shingles

Sample Viva Questions

Q1: A 5-year-old presents with an itchy vesicular rash. How do you manage this?

Model Answer: This is likely chickenpox in a healthy child. Diagnosis is clinical based on the typical rash (crops of vesicles at different stages, centripetal distribution). Management is supportive: paracetamol for fever (NOT NSAIDs due to necrotising fasciitis risk), antihistamines and calamine for itch, keep nails short. Advise parents the child is infectious until all lesions are crusted over (~5-7 days). No antivirals needed for a healthy child. I would ask about contacts who might be high-risk (pregnant women, immunocompromised, neonates) and advise accordingly.

Q2: Why should NSAIDs be avoided in chickenpox?

Model Answer: NSAIDs (particularly ibuprofen) have been associated with an increased risk of invasive Group A Streptococcal infection and necrotising fasciitis in children with chickenpox. Observational studies, including Lesko et al., demonstrated this association. The mechanism may involve masking early signs of infection, impairing neutrophil function, or direct effects on bacterial virulence. NICE and PHE guidelines recommend paracetamol only for symptomatic relief in chickenpox.

Q3: A pregnant woman at 10 weeks gestation is exposed to chickenpox. What is your management?

Model Answer: First, I would check her immunity status. If she has a history of chickenpox or is IgG positive, she is immune and no action is needed. If she is non-immune (IgG negative) and has been significantly exposed (same room for >15 minutes, face-to-face contact, same household), she is at risk of varicella and its complications (pneumonitis, and congenital varicella syndrome). I would administer VZIG as soon as possible (ideally within 10 days of exposure) to prevent or attenuate infection. If she develops varicella, treatment is with aciclovir (especially if ≥20 weeks), and she should be monitored closely for pneumonitis. Detailed fetal medicine follow-up is required for risk of congenital varicella syndrome, which is ~2% when infection occurs between weeks 13-20.

Common Exam Errors

ErrorCorrect Approach
Prescribing ibuprofenUse paracetamol only — NSAIDs increase NF risk
Giving antivirals to all childrenAntivirals only for high-risk groups (adults, immunocompromised, pregnant)
Saying chickenpox is infectious only when rash visibleInfectious 2 days BEFORE rash appears
Forgetting VZIG for high-risk contactsVZIG within 10 days for pregnant, immunocompromised, neonate contacts
Confusing congenital varicella syndrome timingRisk is <20 weeks gestation; after 20 weeks = shingles in infancy, not CVS

Last Reviewed: 2025-12-24 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24

Red Flags

  • Bacterial superinfection (invasive GAS — necrotising fasciitis, sepsis)
  • Pneumonitis (adults, pregnant women, immunocompromised)
  • Encephalitis/cerebellar ataxia
  • Immunocompromised patient with chickenpox
  • Pregnant woman exposed to chickenpox (or with chickenpox)
  • Neonate exposed to maternal chickenpox around delivery

Clinical Pearls

  • **"No NSAIDs"**: Avoid NSAIDs (ibuprofen) in chickenpox — associated with increased risk of secondary necrotising fasciitis. Use paracetamol only for fever.
  • **"The Prodrome Is Non-Specific"**: Fever and malaise for 1-2 days before the rash is common. Don't dismiss non-specific symptoms in contacts of known cases.
  • **Red Flags — Require Urgent Assessment:**
  • - High persistent fever after day 4 (secondary bacterial infection)
  • - Rapidly spreading redness/warmth around lesions (cellulitis, necrotising fasciitis)

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines